(Q34434731)

2 August 2017

1 reference

title

Recent advances in treatment of youth with Type 1 diabetes: better care through technology (English)

1 reference

2 August 2017

0 references

1 reference

Tamborlane WV

1

1 reference

PubMed ID

11703429

2 August 2017

Bonfig W

series ordinal

2

1 reference

PubMed ID

11703429

2 August 2017

Boland E

series ordinal

3

1 reference

2 August 2017

1 November 2001

1 reference

2 August 2017

1 reference

2 August 2017

18

1 reference

2 August 2017

11

1 reference

2 August 2017

864-870

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

2 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00626.X

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00626.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00626.X

Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00626.X

Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00626.X

Decreased epinephrine responses to hypoglycemia during sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00626.X

Effectiveness of postprandial Humalog in toddlers with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00626.X

Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00626.X

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00626.X

Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00626.X

Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. The European Study Group of HOE 901 in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00626.X

Insulin administered intranasally as an insulin-bile salt aerosol. Effectiveness and reproducibility in normal and diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00626.X

Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00626.X

Inhaled human insulin treatment in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00626.X

Hypoglycemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00626.X

Refinement of the 6q chromosomal region implicated in transient neonatal diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00626.X

Counterregulation in peripheral tissues: effect of systemic hypoglycemia on levels of substrates and catecholamines in human skeletal muscle and adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00626.X

Clinical Control of Diabetes by the Artificial Pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00626.X

Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00626.X

Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study

21 January 2018

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.1016/S0168-8227(99)00113-8

Identifiers

DOI

10.1046/J.1464-5491.2001.00626.X

1 reference

2 August 2017

1 reference

PubMed ID

11703429